675 research outputs found
DST831695_Supplemental_Material_CLN – Supplemental material for Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study
No full textSupplemental material, DST831695_Supplemental_Material_CLN for Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study by Norbert Hermanns, Lutz Heinemann, Guido Freckmann, Delia Waldenmaier and Dominic Ehrmann in Journal of Diabetes Science and Technology</p
sj-docx-2-dst-10.1177_19322968241239870 – Supplemental material for Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial
No full textSupplemental material, sj-docx-2-dst-10.1177_19322968241239870 for Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial by Dominic Ehrmann, Norbert Hermanns, Katharina Finke-Gröne, Timm Roos, Johanna Kober, Vanessa Schäfer, Michael Krichbaum, Thomas Haak, Ralph Ziegler, Lutz Heinemann, Cosima Rieger, Ezgi Bingol, Bernhard Kulzer and Stephan Silbermann in Journal of Diabetes Science and Technology</p
sj-docx-1-dst-10.1177_19322968241239870 – Supplemental material for Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial
No full textSupplemental material, sj-docx-1-dst-10.1177_19322968241239870 for Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial by Dominic Ehrmann, Norbert Hermanns, Katharina Finke-Gröne, Timm Roos, Johanna Kober, Vanessa Schäfer, Michael Krichbaum, Thomas Haak, Ralph Ziegler, Lutz Heinemann, Cosima Rieger, Ezgi Bingol, Bernhard Kulzer and Stephan Silbermann in Journal of Diabetes Science and Technology</p
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire)
No full textAttitudes, Type 1 diabetes, Questionnair
Internet-based cognitive-behavioral therapy is effective in reducing depressive symptomatology in type 1 diabetes: results of a randomized controlled trial
Get PDFObjective: Depression in people with diabetes is associated with poorer health outcomes. Although web programs integrating cognitive-behavioral therapy with diabetes education have shown good results, no similar approach has been implemented in Spain. This aim of this study was to administer an Internet-based cognitive-behavioral therapy program (CBT) for the treatment of mild-moderate depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study) and evaluate the efficacy of this program.
Research design and methods: A pre-post randomized controlled study was conducted. The sample comprised 65 people with type 1 diabetes and mild-moderate depressive symptoms: 35 treatment group (TG) and 30 control group (CG). The following effects of the nine-session program were analyzed: depression (Beck Depression Inventory Fast Screen, BDI-FS), metabolic variables (glycosilated hemoglobin, HbA1c), and other psychological variables including anxiety (State Trait Anxiety Inventory, STAI), fear of hypoglycemia (Fear of Hypoglycemia Questionnaire, FH-15), distress (Diabetes Distress Questionnaire (DDS), quality of life (Diabetes Quality of Life Questionnaire, DQOL),and treatment adherence (Diabetes Self-Care Inventory-Revised questionnaire, SCI-R).
Results: At the end of the treatment program, only 28 people were evaluated (TG=8; CG=20). However, a significant reduction was found in both groups in BDI-FS and STAI-T scores, which was significantly greater in the TG. Significant improvements were also found in the TG in DQOL, FH-15, DDS and SCI-R scores. The percentage change in these variables was also statistically significant in the TG versus the CG. However, no significant results were found in HbA1c.The University of Málaga contributed to the financing of this study through its Own Plan with two projects, providing material means for the design of the new treatment website for depression in people with type 1 diabetes (Proyecto Puente of the University of Málaga: Development of a telematic application for the treatment of depression in type 1 diabetes) and development of the same (Proyecto Puente B.5 of the University of Málaga: Evaluation of the effectiveness of a new telematic program for the treatment of depression in patients with type 1 diabetes) as well as personnel (postdoctoral contract). This study was also financed within the framework of the FEDER Andalusia Program 2014-2020 (Reference: UMA20-FEDERJA008)
Correlates and outcomes of worries about hypoglycemia in family members of adults with diabetes: the second Diabetes Attitudes, Wishes and Needs (DAWN2) Study
No full textObjective: We examined (a) the demographic and clinical correlates of worries about hypoglycemia in adult family members of adults with diabetes, and (b) the association of these worries with measures of diabetes support.Methods: The second multinational Diabetes Attitudes, Wishes and Needs (DAWN2) study cross-sectionally surveyed 2057 family members from 17 countries. Participants completed questions about demographics, diabetes, and psychosocial functioning, including worry about overall and nocturnal hypoglycemia. Analyses included hierarchical ordinal and linear regression.Results: Eighty-five percent of family members (n = 1661) were at least occasionally very worried about the risk of hypoglycemic events overall. Correlates of worries about hypoglycemia included female gender, higher age and lower education in the family member, younger age of the person with diabetes and this person being a parent or another adult (versus spouse or partner), insulin or non-insulin injectable treatment, severe or non-severe hypoglycemia in the past 12 months, and family member recognition of hypoglycemia. Elevated worries about hypoglycemia had a significant independent association with increased odds of diabetes-related family arguments and family member frustration in providing helpful support (OR range 1.60–3.72). High levels of worries about hypoglycemia were associated with increased odds of attending diabetes-related health-care visits. Worries about hypoglycemia were not associated with family member involvement in diabetes care. Similar results were found for worries about nocturnal events.Conclusion: Worries about hypoglycemia were common in family members and were associated with suboptimal diabetes support. This issue therefore deserves increased clinician attention
- …
